Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery
{{output}}
Tumor heterogeneity and drug resistance limit the efficacy of cancer therapies and highlight the need for patient-specific preclinical models. Here, we develop a microfluidic tumor-on-chip (TOC) platform that integrates patient-derived organoids with a functio... ...
